In the BioHarmony Drug Report Database

"Preview" Icon

Fostemsavir tromethamine

Rukobia (fostemsavir tromethamine) is a small molecule pharmaceutical. Fostemsavir tromethamine was first approved as Rukobia on 2020-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Rukobia’s patent is valid until 2027-11-19 (FDA).

 

Trade Name

 

Rukobia
 

Common Name

 

fostemsavir tromethamine
 

ChEMBL ID

 

CHEMBL3301598
 

Indication

 

hiv infections
 

Drug Class

 

Antivirals; phosphoro-derivatives

Image (chem structure or protein)

Fostemsavir tromethamine structure rendering